Back to top

New Strong Buy Stocks for August 10th

Read MoreHide Full Article

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:

D.R. Horton, Inc. (DHI - Free Report) : This homebuilding company has seen the Zacks Consensus Estimate for its current year earnings increasing 4% over the last 60 days.

D.R. Horton, Inc. Price and Consensus

 

D.R. Horton, Inc. Price and Consensus

D.R. Horton, Inc. price-consensus-chart | D.R. Horton, Inc. Quote

Peabody Energy Corporation (BTU - Free Report) : This company engaged in coal mining business has seen the Zacks Consensus Estimate for its current year earnings increasing 24.8% over the last 60 days.

Petróleo Brasileiro S.A. - Petrobras (PBR - Free Report) : This company that operates in the oil, natural gas, and energy industries has seen the Zacks Consensus Estimate for its current year earnings increasing 29.8% over the last 60 days.

Petroleo Brasileiro S.A.- Petrobras Price and Consensus

 

Petroleo Brasileiro S.A.- Petrobras Price and Consensus

Petroleo Brasileiro S.A.- Petrobras price-consensus-chart | Petroleo Brasileiro S.A.- Petrobras Quote

Entegris, Inc. (ENTG - Free Report) : This company that manufactures, and supplies microcontamination control products has seen the Zacks Consensus Estimate for its current year earnings increasing 7.7% over the last 60 days.

Entegris, Inc. Price and Consensus

 

Entegris, Inc. Price and Consensus

Entegris, Inc. price-consensus-chart | Entegris, Inc. Quote

Textainer Group Holdings Limited (TGH - Free Report) : This company that engages in the purchase, ownership, management, leasing, and disposal of a fleet of intermodal containers has seen the Zacks Consensus Estimate for its current year earnings increasing 2.2% over the last 60 days.

Textainer Group Holdings Limited Price and Consensus

 

Textainer Group Holdings Limited Price and Consensus

Textainer Group Holdings Limited price-consensus-chart | Textainer Group Holdings Limited Quote

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>



More from Zacks Zacks #1 Rank Additions

You May Like